BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10697069)

  • 1. Psychotropic drug use in very young children.
    Coyle JT
    JAMA; 2000 Feb; 283(8):1059-60. PubMed ID: 10697069
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in the prescribing of psychotropic medications to preschoolers.
    Zito JM; Safer DJ; dosReis S; Gardner JF; Boles M; Lynch F
    JAMA; 2000 Feb; 283(8):1025-30. PubMed ID: 10697062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.
    Rosenberg M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-7. PubMed ID: 15744950
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
    Salmelainen P
    N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
    [No Abstract]   [Full Text] [Related]  

  • 5. Bad Medicine: Psychiatric medicine.
    Spence D
    Br J Gen Pract; 2018 Dec; 68(677):583. PubMed ID: 30498152
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription of methylphenidate to children and youth, 1990-1996.
    Miller AR; Lalonde CE; McGrail KM; Armstrong RW
    CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS; Olfson M; Mojtabai R
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
    Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
    Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drugs and preschoolers.
    Rey JM; Walter G; Hazell PL
    Med J Aust; 2000 Aug; 173(4):172-3. PubMed ID: 11008585
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of growth hormone for non-growth hormone deficient children.
    Diller L
    JAMA; 1996 Dec; 276(23):1877-8; author reply 1878. PubMed ID: 8968011
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic drug use rising among preschoolers.
    Miller JL
    Am J Health Syst Pharm; 2000 Apr; 57(8):732, 735. PubMed ID: 10786257
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of Youths Treated With Psychotropic Polypharmacy in the United States, 1999 to 2015.
    Zhang C; Spence O; Reeves G; dosReis S
    JAMA Pediatr; 2021 Feb; 175(2):196-198. PubMed ID: 33136150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory action and moderate decrease in methylphenidate use among ADHD diagnosed patients aged five and under in Korea.
    Shin JY; Lee SH; Shin SM; Shin HN; Park BJ
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):244-8. PubMed ID: 25957571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
    Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
    Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child psychopharmacology: politics versus science.
    Levy F
    Aust N Z J Psychiatry; 2013 Oct; 47(10):961. PubMed ID: 23888073
    [No Abstract]   [Full Text] [Related]  

  • 17. Time for some reason in the ADHD debate.
    Starling J
    Aust N Z J Psychiatry; 2013 Oct; 47(10):958-9. PubMed ID: 23888075
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Whitely: a caution from the coalface.
    Levy F
    Aust N Z J Psychiatry; 2012 May; 46(5):404-6. PubMed ID: 22535290
    [No Abstract]   [Full Text] [Related]  

  • 19. Correspondence (letter to the editor): What about the dam break upstream?
    Börner J
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):918-9. PubMed ID: 21249140
    [No Abstract]   [Full Text] [Related]  

  • 20. Correspondence (letter to the editor): Uncritical prescription.
    Neraal T
    Dtsch Arztebl Int; 2010 Dec; 107(51-52):919; author reply 919-20. PubMed ID: 21249142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.